Easton Capital Investment Group — Full Portfolio
4 tracked investments · listed companies and verified rows first
BiotechSan Francisco, US
Philip Fung(Executive Officer, Director)
BoardRoberto Sanabria(Director)in
Co-investorsExpaStartXKaiser Permanente VenturesLionBirdNew Leaf Venture PartnersSands Capital Ventures
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)inTimothy Kress-Spatz(Executive Officer)
Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdRex Health VenturesNew Leaf Venture PartnersRock Health+1 more
BiotechMalvern, US
Mark Lupher(Executive Officer)Dominick C. Colangelo(Executive Officer, Director)
BoardJames W. Broderick, M.D.(Director)Geert-Jan Mulder(Director)inJohn Friedman(Director)inHarold R. Werner(Director)
Co-investorsEaston CapitalSofinnova VenturesForbion
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








